The Therapeutic Value of Monoclonal Antibodies Directed Against Immunogenic Tumor Glycoproteins
<p>Monoclonal antibodies developed against immunogenic proteins (Tumor Specific Antigens/TSA's) that are expressed in human cancers, display a unique behavioral pattern. They appear to serve in a dual role. This includes the early recognition of these immunogenic membrane proteins that ca...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Ivyspring International Publisher
2010-01-01
|
Series: | Journal of Cancer |
Online Access: | http://www.jcancer.org/v01p0209.htm |